ID   KCC2B_HUMAN             Reviewed;         666 AA.
AC   Q13554; A4D2K0; A4D2K1; A4D2K2; A4D2K3; A4D2K4; A4D2K5; A4D2K6;
AC   O95437; O95438; O95599; Q9UGH7; Q9UGH8; Q9UGH9; Q9UNX0; Q9UNX7;
AC   Q9UP00; Q9Y5N4; Q9Y6F4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   31-MAY-2011, sequence version 3.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type II subunit beta;
DE            Short=CaM kinase II subunit beta;
DE            Short=CaMK-II subunit beta;
DE            EC=2.7.11.17;
GN   Name=CAMK2B; Synonyms=CAM2, CAMK2, CAMKB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 5; 6 AND 7).
RC   TISSUE=Brain;
RX   PubMed=10858498; DOI=10.1016/S0014-5793(00)01634-3;
RA   Wang P., Wu Y., Zhou T.H., Sun Y., Pei G.;
RT   "Identification of alternative splicing variants of the beta subunit
RT   of human Ca(2+)/calmodulin-dependent protein kinase II with different
RT   activities.";
RL   FEBS Lett. 475:107-110(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Skeletal muscle;
RA   Leddy J.J., Salih M., Tuana B.S.;
RL   Submitted (MAR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Brain;
RA   Li G.Y., Cooper N.G.F.;
RT   "Molecular cloning and sequencing of human calcium/calmodulin
RT   dependent protein kinase II beta subunit.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 5).
RC   TISSUE=Insulinoma;
RX   PubMed=10819240; DOI=10.1007/s001250051330;
RA   Rochlitz H., Voigt A., Lankat-Buttgereit B., Goeke B., Heimberg H.,
RA   Nauck M.A., Schiemann U., Schatz H., Pfeiffer A.F.;
RT   "Cloning and quantitative determination of the human Ca2+/calmodulin-
RT   dependent protein kinase II (CaMK II) isoforms in human beta cells.";
RL   Diabetologia 43:465-473(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 302-605 (ISOFORM 2).
RX   PubMed=9060999; DOI=10.1016/S0167-4889(96)00141-3;
RA   Tombes R.M., Krystal G.W.;
RT   "Identification of novel human tumor cell-specific CaMK-II variants.";
RL   Biochim. Biophys. Acta 1355:281-292(1997).
RN   [9]
RP   ENZYME REGULATION, SUBUNIT, AND AUTOPHOSPHORYLATION.
RX   PubMed=14722083; DOI=10.1074/jbc.M313597200;
RA   Gaertner T.R., Kolodziej S.J., Wang D., Kobayashi R., Koomen J.M.,
RA   Stoops J.K., Waxham M.N.;
RT   "Comparative analyses of the three-dimensional structures and
RT   enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-
RT   calmodulin-dependent protein kinase II.";
RL   J. Biol. Chem. 279:12484-12494(2004).
RN   [10]
RP   INTERACTION WITH MPDZ.
RX   PubMed=15312654; DOI=10.1016/j.neuron.2004.08.003;
RA   Krapivinsky G., Medina I., Krapivinsky L., Gapon S., Clapham D.E.;
RT   "SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase
RT   activity and NMDA receptor-dependent synaptic AMPA receptor
RT   potentiation.";
RL   Neuron 43:563-574(2004).
RN   [11]
RP   FUNCTION IN SKELETAL MUSCLE, PHOSPHORYLATION AT THR-287, FUNCTION IN
RP   PHOSPHORYLATION OF PLN, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16690701; DOI=10.1113/jphysiol.2006.111757;
RA   Rose A.J., Kiens B., Richter E.A.;
RT   "Ca2+-calmodulin-dependent protein kinase expression and signalling in
RT   skeletal muscle during exercise.";
RL   J. Physiol. (Lond.) 574:889-903(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21529938; DOI=10.1016/j.ceca.2011.02.007;
RA   Wayman G.A., Tokumitsu H., Davare M.A., Soderling T.R.;
RT   "Analysis of CaM-kinase signaling in cells.";
RL   Cell Calcium 50:1-8(2011).
RN   [14]
RP   REVIEW ON FUNCTION IN SKELETAL MUSCLE.
RX   PubMed=15294044; DOI=10.1079/PNS2004335;
RA   Chin E.R.;
RT   "The role of calcium and calcium/calmodulin-dependent kinases in
RT   skeletal muscle plasticity and mitochondrial biogenesis.";
RL   Proc. Nutrit. Soc. 63:279-286(2004).
RN   [15]
RP   REVIEW ON FUNCTION IN SKELETAL MUSCLE.
RA   Sacchetto R., Bovo E., Damiani E.;
RT   "The Ca2+-calmodulin dependent protein kinase II system of skeletal
RT   muscle sarcoplasmic reticulum.";
RL   Basic Appl. Myol. 15:5-17(2005).
RN   [16]
RP   REVIEW ON FUNCTION IN NEURONAL PLASTICITY.
RX   PubMed=18817731; DOI=10.1016/j.neuron.2008.08.021;
RA   Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A.,
RA   Soderling T.R.;
RT   "Calmodulin-kinases: modulators of neuronal development and
RT   plasticity.";
RL   Neuron 59:914-931(2008).
RN   [17]
RP   REVIEW ON FUNCTION IN NEURONAL PLASTICITY.
RX   PubMed=19996366; DOI=10.1152/physiol.00029.2009;
RA   Okamoto K., Bosch M., Hayashi Y.;
RT   "The roles of CaMKII and F-actin in the structural plasticity of
RT   dendritic spines: a potential molecular identity of a synaptic tag?";
RL   Physiology (Bethesda) 24:357-366(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 11-303 IN COMPLEX WITH
RP   INHIBITOR.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human calcium/calmodulin-dependent protein
RT   kinase IIb isoform 1 (CAMK2B).";
RL   Submitted (DEC-2007) to the PDB data bank.
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-489 AND LYS-510.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that
CC       functions autonomously after Ca(2+)/calmodulin-binding and
CC       autophosphorylation, and is involved in dendritic spine and
CC       synapse formation, neuronal plasticity and regulation of
CC       sarcoplasmic reticulum Ca(2+) transport in skeletal muscle. In
CC       neurons, plays an essential structural role in the reorganization
CC       of the actin cytoskeleton during plasticity by binding and
CC       bundling actin filaments in a kinase-independent manner. This
CC       structural function is required for correct targeting of CaMK2A,
CC       which acts downstream of NMDAR to promote dendritic spine and
CC       synapse formation and maintain synaptic plasticity which enables
CC       long-term potentiation (LTP) and hippocampus-dependent learning.
CC       In developing hippocampal neurons, promotes arborization of the
CC       dendritic tree and in mature neurons, promotes dendritic
CC       remodeling. Participates in the modulation of skeletal muscle
CC       function in response to exercise. In slow-twitch muscles, is
CC       involved in regulation of sarcoplasmic reticulum (SR) Ca(2+)
CC       transport and in fast-twitch muscle participates in the control of
CC       Ca(2+) release from the SR through phosphorylation of triadin, a
CC       ryanodine receptor-coupling factor, and phospholamban (PLN/PLB),
CC       an endogenous inhibitor of SERCA2A/ATP2A2.
CC       {ECO:0000269|PubMed:16690701}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves
CC       intrasteric autoinhibition and allows autophosphorylation of Thr-
CC       287 which turns the kinase in a constitutively active form and
CC       confers to the kinase a Ca(2+)-independent activity.
CC       {ECO:0000269|PubMed:14722083}.
CC   -!- SUBUNIT: CAMK2 is composed of 4 different chains: alpha (CAMK2A),
CC       beta (CAMK2B), gamma (CAMK2G), and delta (CAMK2D). The different
CC       isoforms assemble into homo- or heteromultimeric holoenzymes
CC       composed of 12 subunits with two hexameric rings stacked one on
CC       top of the other (PubMed:14722083, Ref.19). Interacts with SYNGAP1
CC       and CAMK2N2 (By similarity). Interacts with MPDZ
CC       (PubMed:15312654). Interacts with FOXO3 (By similarity).
CC       {ECO:0000250|UniProtKB:P08413, ECO:0000250|UniProtKB:Q13554,
CC       ECO:0000269|PubMed:14722083, ECO:0000269|PubMed:15312654,
CC       ECO:0000269|Ref.19}.
CC   -!- INTERACTION:
CC       B3KWQ7:-; NbExp=3; IntAct=EBI-1058722, EBI-10175974;
CC       O00154:ACOT7; NbExp=3; IntAct=EBI-1058722, EBI-948905;
CC       Q2VPB7:AP5B1; NbExp=3; IntAct=EBI-1058722, EBI-5917279;
CC       Q13555-5:CAMK2G; NbExp=4; IntAct=EBI-11523526, EBI-12020154;
CC       Q8N0U1:FAM171A2; NbExp=3; IntAct=EBI-1058722, EBI-10264767;
CC       P60412:KRTAP10-11; NbExp=3; IntAct=EBI-1058722, EBI-10217483;
CC       Q3LI72:KRTAP19-5; NbExp=3; IntAct=EBI-1058722, EBI-1048945;
CC       Q3SYF9:KRTAP19-7; NbExp=3; IntAct=EBI-1058722, EBI-10241353;
CC       Q9UI95:MAD2L2; NbExp=3; IntAct=EBI-1058722, EBI-77889;
CC       Q9BUE0:MED18; NbExp=3; IntAct=EBI-1058722, EBI-394640;
CC       Q9UBU8:MORF4L1; NbExp=3; IntAct=EBI-1058722, EBI-399246;
CC       Q9UBU8-2:MORF4L1; NbExp=3; IntAct=EBI-1058722, EBI-10288852;
CC       Q9Y3B7:MRPL11; NbExp=3; IntAct=EBI-1058722, EBI-5453723;
CC       Q93100:PHKB; NbExp=3; IntAct=EBI-1058722, EBI-740559;
CC       Q969H6:POP5; NbExp=3; IntAct=EBI-1058722, EBI-366525;
CC       P61225:RAP2B; NbExp=3; IntAct=EBI-1058722, EBI-750871;
CC       O43251:RBFOX2; NbExp=3; IntAct=EBI-1058722, EBI-746056;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-1058722, EBI-740322;
CC       P62913:RPL11; NbExp=3; IntAct=EBI-1058722, EBI-354380;
CC       Q9NTN9-3:SEMA4G; NbExp=3; IntAct=EBI-1058722, EBI-9089805;
CC       Q5W111:SPRYD7; NbExp=3; IntAct=EBI-1058722, EBI-10248098;
CC       Q8N0Z6:TTC5; NbExp=3; IntAct=EBI-1058722, EBI-9526213;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:21529938}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome {ECO:0000250}.
CC       Sarcoplasmic reticulum membrane {ECO:0000269|PubMed:21529938};
CC       Peripheral membrane protein {ECO:0000269|PubMed:21529938};
CC       Cytoplasmic side {ECO:0000269|PubMed:21529938}. Note=In slow-
CC       twitch muscle, evenly distributed between longitudinal SR and
CC       junctional SR.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=The variable region of the CAMK2B protein is encoded by
CC         at least 7 exons (V1 to V7). Alternative splicing within this
CC         region gives rise to CAMK2B isoforms.;
CC       Name=4;
CC         IsoId=Q13554-1; Sequence=Displayed;
CC       Name=1; Synonyms=Beta;
CC         IsoId=Q13554-2; Sequence=VSP_004776;
CC       Name=2; Synonyms=Beta1, Beta'E;
CC         IsoId=Q13554-3; Sequence=VSP_004770, VSP_004771, VSP_004775,
CC                                  VSP_004776;
CC         Note=Ref.1 (AAD42036) sequence is in conflict in position:
CC         316:A->V. {ECO:0000305};
CC       Name=3; Synonyms=Beta2;
CC         IsoId=Q13554-4; Sequence=VSP_004770, VSP_004771, VSP_004774,
CC                                  VSP_004776;
CC       Name=5; Synonyms=Beta4, BetaE;
CC         IsoId=Q13554-5; Sequence=VSP_004770, VSP_004771, VSP_004776;
CC       Name=6; Synonyms=Beta6;
CC         IsoId=Q13554-6; Sequence=VSP_004773, VSP_004776, VSP_004777;
CC       Name=7; Synonyms=Beta7;
CC         IsoId=Q13554-7; Sequence=VSP_004770, VSP_004772;
CC       Name=8;
CC         IsoId=Q13554-8; Sequence=VSP_041219, VSP_004776;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in adult and fetal
CC       brain. Expression is slightly lower in fetal brain. Expressed in
CC       skeletal muscle. {ECO:0000269|PubMed:16690701}.
CC   -!- INDUCTION: Activity is induced in skeletal muscle during exercise.
CC       {ECO:0000269|PubMed:16690701}.
CC   -!- DOMAIN: The CAMK2 protein kinases contain a unique C-terminal
CC       subunit association domain responsible for oligomerization.
CC   -!- PTM: Autophosphorylation of Thr-287 following activation by
CC       Ca(2+)/calmodulin. Phosphorylation of Thr-287 locks the kinase
CC       into an activated state. {ECO:0000269|PubMed:16690701}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC99802.1; Type=Frameshift; Positions=426, 433, 511, 516; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF078803; AAD42035.1; -; mRNA.
DR   EMBL; AF081572; AAD42036.1; -; mRNA.
DR   EMBL; AF081924; AAD42037.1; -; mRNA.
DR   EMBL; AF083419; AAD42038.1; -; mRNA.
DR   EMBL; AF140350; AAD42070.1; -; mRNA.
DR   EMBL; U23460; AAC99802.1; ALT_FRAME; mRNA.
DR   EMBL; AF112472; AAD03744.1; -; mRNA.
DR   EMBL; AF112471; AAD03743.1; -; mRNA.
DR   EMBL; AJ252236; CAB65120.1; -; mRNA.
DR   EMBL; AJ252237; CAB65121.1; -; mRNA.
DR   EMBL; AJ252238; CAB65122.1; -; mRNA.
DR   EMBL; AK290148; BAF82837.1; -; mRNA.
DR   EMBL; AK315663; BAG38029.1; -; mRNA.
DR   EMBL; CH236960; EAL23756.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23757.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23758.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23759.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23760.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23761.1; -; Genomic_DNA.
DR   EMBL; CH236960; EAL23762.1; -; Genomic_DNA.
DR   EMBL; BC019070; AAH19070.1; -; mRNA.
DR   EMBL; U50358; AAB16863.1; -; mRNA.
DR   CCDS; CCDS43573.1; -. [Q13554-8]
DR   CCDS; CCDS5483.1; -. [Q13554-1]
DR   CCDS; CCDS5484.1; -. [Q13554-2]
DR   CCDS; CCDS5485.1; -. [Q13554-5]
DR   CCDS; CCDS5486.1; -. [Q13554-3]
DR   CCDS; CCDS5487.1; -. [Q13554-6]
DR   CCDS; CCDS5488.1; -. [Q13554-4]
DR   CCDS; CCDS5489.1; -. [Q13554-7]
DR   RefSeq; NP_001211.3; NM_001220.4. [Q13554-1]
DR   RefSeq; NP_001280099.1; NM_001293170.1. [Q13554-2]
DR   RefSeq; NP_742075.1; NM_172078.2. [Q13554-2]
DR   RefSeq; NP_742076.1; NM_172079.2. [Q13554-5]
DR   RefSeq; NP_742077.1; NM_172080.2. [Q13554-8]
DR   RefSeq; NP_742078.1; NM_172081.2. [Q13554-3]
DR   RefSeq; NP_742079.1; NM_172082.2. [Q13554-6]
DR   RefSeq; NP_742080.1; NM_172083.2. [Q13554-4]
DR   RefSeq; NP_742081.1; NM_172084.2. [Q13554-7]
DR   UniGene; Hs.351887; -.
DR   PDB; 3BHH; X-ray; 2.40 A; A/B/C/D=11-303.
DR   PDBsum; 3BHH; -.
DR   ProteinModelPortal; Q13554; -.
DR   SMR; Q13554; -.
DR   BioGrid; 107266; 46.
DR   DIP; DIP-39770N; -.
DR   IntAct; Q13554; 45.
DR   STRING; 9606.ENSP00000379098; -.
DR   BindingDB; Q13554; -.
DR   ChEMBL; CHEMBL4121; -.
DR   DrugBank; DB07168; [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile.
DR   GuidetoPHARMACOLOGY; 1556; -.
DR   iPTMnet; Q13554; -.
DR   PhosphoSitePlus; Q13554; -.
DR   BioMuta; CAMK2B; -.
DR   DMDM; 334302890; -.
DR   MaxQB; Q13554; -.
DR   PaxDb; Q13554; -.
DR   PeptideAtlas; Q13554; -.
DR   PRIDE; Q13554; -.
DR   DNASU; 816; -.
DR   Ensembl; ENST00000258682; ENSP00000258682; ENSG00000058404. [Q13554-8]
DR   Ensembl; ENST00000346990; ENSP00000326518; ENSG00000058404. [Q13554-7]
DR   Ensembl; ENST00000347193; ENSP00000326544; ENSG00000058404. [Q13554-6]
DR   Ensembl; ENST00000350811; ENSP00000326375; ENSG00000058404. [Q13554-2]
DR   Ensembl; ENST00000353625; ENSP00000326427; ENSG00000058404. [Q13554-4]
DR   Ensembl; ENST00000358707; ENSP00000351542; ENSG00000058404. [Q13554-3]
DR   Ensembl; ENST00000395747; ENSP00000379096; ENSG00000058404. [Q13554-5]
DR   Ensembl; ENST00000395749; ENSP00000379098; ENSG00000058404. [Q13554-1]
DR   Ensembl; ENST00000440254; ENSP00000397937; ENSG00000058404. [Q13554-2]
DR   Ensembl; ENST00000457475; ENSP00000390292; ENSG00000058404. [Q13554-5]
DR   GeneID; 816; -.
DR   KEGG; hsa:816; -.
DR   UCSC; uc003tkp.3; human. [Q13554-1]
DR   CTD; 816; -.
DR   DisGeNET; 816; -.
DR   GeneCards; CAMK2B; -.
DR   HGNC; HGNC:1461; CAMK2B.
DR   HPA; CAB006849; -.
DR   HPA; HPA026307; -.
DR   HPA; HPA051783; -.
DR   HPA; HPA051785; -.
DR   HPA; HPA053973; -.
DR   MIM; 607707; gene.
DR   neXtProt; NX_Q13554; -.
DR   OpenTargets; ENSG00000058404; -.
DR   PharmGKB; PA91; -.
DR   eggNOG; KOG0033; Eukaryota.
DR   eggNOG; ENOG410XNRX; LUCA.
DR   GeneTree; ENSGT00760000118944; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q13554; -.
DR   KO; K04515; -.
DR   OMA; VGPPPCL; -.
DR   OrthoDB; EOG091G0SCS; -.
DR   PhylomeDB; Q13554; -.
DR   TreeFam; TF315229; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-399719; Trafficking of AMPA receptors.
DR   Reactome; R-HSA-438066; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; R-HSA-442729; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; R-HSA-442742; CREB phosphorylation through the activation of Ras.
DR   Reactome; R-HSA-442982; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; R-HSA-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   SignaLink; Q13554; -.
DR   SIGNOR; Q13554; -.
DR   EvolutionaryTrace; Q13554; -.
DR   GeneWiki; CAMK2B; -.
DR   GenomeRNAi; 816; -.
DR   PRO; PR:Q13554; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000058404; -.
DR   ExpressionAtlas; Q13554; baseline and differential.
DR   Genevisible; Q13554; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0051924; P:regulation of calcium ion transport; TAS:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060998; P:regulation of dendritic spine development; TAS:UniProtKB.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; TAS:UniProtKB.
DR   GO; GO:0014733; P:regulation of skeletal muscle adaptation; TAS:UniProtKB.
DR   GO; GO:0051823; P:regulation of synapse structural plasticity; TAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR013543; Ca/CaM-dep_prot_kinase-assoc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR032710; NTF2-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF08332; CaMKII_AD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54427; SSF54427; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Differentiation; Kinase; Membrane;
KW   Neurogenesis; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Sarcoplasmic reticulum;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    666       Calcium/calmodulin-dependent protein
FT                                kinase type II subunit beta.
FT                                /FTId=PRO_0000086096.
FT   DOMAIN       14    272       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      20     28       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      283    292       Autoinhibitory domain. {ECO:0000250}.
FT   REGION      291    301       Calmodulin-binding.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      43     43       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      17     17       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     287    287       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:16690701}.
FT   MOD_RES     306    306       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     307    307       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08413}.
FT   MOD_RES     394    394       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P08413}.
FT   MOD_RES     400    400       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P28652}.
FT   MOD_RES     401    401       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     316    340       Missing (in isoform 8). {ECO:0000305}.
FT                                /FTId=VSP_041219.
FT   VAR_SEQ     316    316       V -> A (in isoform 2, isoform 3, isoform
FT                                5 and isoform 7).
FT                                {ECO:0000303|PubMed:10819240,
FT                                ECO:0000303|PubMed:10858498,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9060999,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004770.
FT   VAR_SEQ     317    533       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:10858498}.
FT                                /FTId=VSP_004772.
FT   VAR_SEQ     317    340       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:10819240,
FT                                ECO:0000303|PubMed:10858498,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9060999,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004771.
FT   VAR_SEQ     354    392       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10819240}.
FT                                /FTId=VSP_004774.
FT   VAR_SEQ     354    377       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:10858498}.
FT                                /FTId=VSP_004773.
FT   VAR_SEQ     379    393       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10819240,
FT                                ECO:0000303|PubMed:10858498,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9060999}.
FT                                /FTId=VSP_004775.
FT   VAR_SEQ     410    533       Missing (in isoform 1, isoform 2, isoform
FT                                3, isoform 5, isoform 6 and isoform 8).
FT                                {ECO:0000303|PubMed:10819240,
FT                                ECO:0000303|PubMed:10858498,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9060999,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004776.
FT   VAR_SEQ     559    584       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:10858498}.
FT                                /FTId=VSP_004777.
FT   VARIANT     489    489       P -> L (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs555460132).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045581.
FT   VARIANT     510    510       E -> K (in dbSNP:rs35452727).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045582.
FT   CONFLICT     68     68       L -> V (in Ref. 3; AAD03744/AAD03743).
FT                                {ECO:0000305}.
FT   CONFLICT    535    535       K -> N (in Ref. 8; AAB16863).
FT                                {ECO:0000305}.
FT   STRAND       14     19       {ECO:0000244|PDB:3BHH}.
FT   STRAND       27     33       {ECO:0000244|PDB:3BHH}.
FT   TURN         34     36       {ECO:0000244|PDB:3BHH}.
FT   STRAND       39     46       {ECO:0000244|PDB:3BHH}.
FT   HELIX        52     67       {ECO:0000244|PDB:3BHH}.
FT   STRAND       76     81       {ECO:0000244|PDB:3BHH}.
FT   STRAND       83     91       {ECO:0000244|PDB:3BHH}.
FT   STRAND       95     97       {ECO:0000244|PDB:3BHH}.
FT   HELIX        98    102       {ECO:0000244|PDB:3BHH}.
FT   HELIX       110    129       {ECO:0000244|PDB:3BHH}.
FT   HELIX       139    141       {ECO:0000244|PDB:3BHH}.
FT   STRAND      142    145       {ECO:0000244|PDB:3BHH}.
FT   STRAND      153    155       {ECO:0000244|PDB:3BHH}.
FT   HELIX       178    180       {ECO:0000244|PDB:3BHH}.
FT   HELIX       183    186       {ECO:0000244|PDB:3BHH}.
FT   HELIX       194    209       {ECO:0000244|PDB:3BHH}.
FT   HELIX       219    228       {ECO:0000244|PDB:3BHH}.
FT   TURN        235    238       {ECO:0000244|PDB:3BHH}.
FT   STRAND      239    241       {ECO:0000244|PDB:3BHH}.
FT   HELIX       243    252       {ECO:0000244|PDB:3BHH}.
FT   TURN        257    259       {ECO:0000244|PDB:3BHH}.
FT   HELIX       263    266       {ECO:0000244|PDB:3BHH}.
FT   HELIX       270    273       {ECO:0000244|PDB:3BHH}.
FT   HELIX       275    278       {ECO:0000244|PDB:3BHH}.
FT   HELIX       285    298       {ECO:0000244|PDB:3BHH}.
SQ   SEQUENCE   666 AA;  72678 MW;  8CACFC3E392C3857 CRC64;
     MATTVTCTRF TDEYQLYEDI GKGAFSVVRR CVKLCTGHEY AAKIINTKKL SARDHQKLER
     EARICRLLKH SNIVRLHDSI SEEGFHYLVF DLVTGGELFE DIVAREYYSE ADASHCIQQI
     LEAVLHCHQM GVVHRDLKPE NLLLASKCKG AAVKLADFGL AIEVQGDQQA WFGFAGTPGY
     LSPEVLRKEA YGKPVDIWAC GVILYILLVG YPPFWDEDQH KLYQQIKAGA YDFPSPEWDT
     VTPEAKNLIN QMLTINPAKR ITAHEALKHP WVCQRSTVAS MMHRQETVEC LKKFNARRKL
     KGAILTTMLA TRNFSVGRQT TAPATMSTAA SGTTMGLVEQ AKSLLNKKAD GVKPQTNSTK
     NSAAATSPKG TLPPAALEPQ TTVIHNPVDG IKESSDSANT TIEDEDAKAP RVPDILSSVR
     RGSGAPEAEG PLPCPSPAPF SPLPAPSPRI SDILNSVRRG SGTPEAEGPL SAGPPPCLSP
     ALLGPLSSPS PRISDILNSV RRGSGTPEAE GPSPVGPPPC PSPTIPGPLP TPSRKQEIIK
     TTEQLIEAVN NGDFEAYAKI CDPGLTSFEP EALGNLVEGM DFHRFYFENL LAKNSKPIHT
     TILNPHVHVI GEDAACIAYI RLTQYIDGQG RPRTSQSEET RVWHRRDGKW QNVHFHCSGA
     PVAPLQ
//
